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Summary. Background and Objective. Cerebral gliomas have a tendency to infiltrate the sur-
rounding brain tissue for several centimeters from the core of tumor. The usefulness of structural 
magnetic resonance (MR) sequences is limited because of their insensitivity for the detection of tumor 
cells outside the visible tumor border. The aim of this study was to investigate the validity and the 
repeatability of 2 functional MR methods: fractional anisotropy (FA) and spectroscopy in the as-
sessment of the peritumoral area of cerebral gliomas.
Material and Methods. Forty-five patients with histologically verified brain gliomas underwent 
diffusion tensor imaging (DTI) and MR spectroscopy (MRS). Metabolic ratios were calculated 
from choline (Cho), creatine (Cr), N-acetylaspartate (NAA), lactate/lipids (LL), myo-inositol (MI) 
spectroscopic values obtained within the tumor center, perifocal edema, and distant and contralat-
eral normal-appearing white matter. DTI maps of FA were calculated at the same locations. 
Results. A significant gradual increase of FA and a decrease of LL/Cr ratios from the tumor 
center to the normal-appearing white matter were observed. The Cho/Cr ratio was significantly 
lower in the distant normal-appearing white matter than in the perifocal edema and the tumor 
center. The NAA/Cr ratio was significantly reduced in the tumor center, perifocal edema, and dis-
tant normal-appearing white matter compared with the contralateral hemisphere. MRS and DTI 
measurements of glioma and peritumoral area had a high degree of repeatability.
Conclusions. Our study shows that MRS and DTI measurements are reproducible. The com-
bined use of Cho/Cr, LL/Cr, and FA measurements is a promising MR technique that provides 
valuable additional information about the location of glioma potential border. 
Introduction
Glioma is the most common malignant primary 
tumor that arises in the brain (1). Despite the de-
velopment of advanced surgical techniques, new 
methods of focused radiotherapy, and novel chemo-
therapy schemes, the majority of glial brain tumors 
recur (2) due to the invasive growth pattern (3). 
Malignant infiltrative brain gliomas have a tendency 
to infiltrate the surrounding white matter for sev-
eral centimeters from the core of tumor (4). The 
recognition of gliomas border invasion is a relevant 
clinical problem (5). The use of conventional struc-
tural magnetic resonance (MR) sequences is limited 
because of their insensitivity for the detection of tu-
mor cells outside the visible tumor border (4, 6).
MR spectroscopy (MRS) is a noninvasive imag-
ing of metabolic changes within the brain (7, 8). It 
can provide quantitative information about the main 
metabolites, which are involved in different pro-
cesses in the nervous system (9). N-acetylaspartate 
(NAA) is as an axonal marker (6). The concentra-
tion of NAA decreases in many diseases of white 
matter, including leukodystrophies, multiple scle-
rosis, and malignant tumors (10). Choline (Cho) is 
a marker of cell membrane (6). It increases in brain 
tumors and inflammation (10). Creatine (Cr) is a 
marker of energy metabolism (6, 10). Cr is consid-
ered a stable metabolite. It is used as a reference for 
relative metabolite quantification (11). Lactate is a 
product of anaerobic glycolysis. It increases in brain 
ischemia, hypoxia, seizures, metabolic disorders 
and acute inflammation, and necrotic and cystic 
tumors (10). Lipids are the products of brain de-
struction. An elevation in lipid levels is observed 
in infarction, acute multiple sclerosis, or necrosis 
(12). Myo-inositol (MI) locates in brain glial cells 
and acts as an osmolyte; the concentration of MI 
is altered in different disorders of the brain in-
cluding Alzheimer’s disease and tumors (13). The 
usefulness of various metabolite concentrations 
or ratios for predicting the grade (14), extent (6), 
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and prognosis (8) of glial brain tumors has been 
reported. 
In parallel, the diffusion tensor imaging (DTI) 
sequence was developed and has an application in 
the evaluation of white matter pathways by meas-
uring the degree and directionality of water diffu-
sion in the tissue. Fractional anisotropy (FA) is a 
commonly used DTI measure for the assessment of 
white matter organization. It is higher in densely 
packed, parallel white matter fibers and alternates 
in various diseases of the brain, which impair white 
matter integrity (15). Combination of MRS and 
DTI is expected to further improve an assessment of 
glial tumor infiltration area (16).
Although various studies indicate that DTI and 
MRS quantitative measurements can provide ad-
ditional information in the diagnostics and moni-
toring of glial tumors, it is necessary to determine 
the repeatability of the tests so that they could be 
more widely used in clinical practice. However, the 
reproducibility of DTI- and MRS-derived indices 
has been not systematically analyzed in the litera-
ture yet. Even less repeatability research has been 
conducted from patients with glial brain tumor. A 
thorough literature search revealed to us that a few 
studies established data on the repeatability of the 
measurements of FA and metabolite ratios. One of 
these studies tested only the repeatability of the in-
dividual metabolites (not metabolite ratios) solely 
in the central part of the tumor (17). Some authors 
have studied the individual metabolite measure-
ment repeatability of the brain in healthy subjects 
(15, 18). However, these studies have not calculated 
the repeatability index. One of the studies analyzed 
the repeatability coefficient of FA measurements in 
patients with glioblastoma (19). However, in this 
study, measurements were made  in the central area 
of  the tumor, but the peritumoral areas and the con-
tralateral white matter were not analyzed (19). To 
the best of our knowledge, no studies on the re-
peatability index test in MRS and DTI quantitative 
measurements of the peritumoral area of cerebral 
gliomas and the contralateral white matter have 
been conducted. This is the first study testing for 
repeatability index in both the FA and the metabo-
lite ratio measurements in several areas of the brain 
in glial tumor patients included the tumor center, 
the perifocal edema, the distant and the contralat-
eral normal-appearing white matter. 
We hypothesized that the combination of DTI 
and MRS could add a relevant diagnostic value for 
the recognition of invasive tumor cells in the peritu-
moral area of gliomas and a more precise evaluation 
of the real tumor spread zone, and far exceeds the 
diagnostic value of structural MR imaging alone. 
The objective of this study was a quantitative 
study of the values of FA and metabolite ratios in the 
peritumoral zone of brain gliomas, including the re-
peatability test of MRS- and DTI-derived measures.
Material and Methods
This cross-sectional trial was reviewed and ap-
proved by the Ethics Committee of Riga Stradins 
University and the local institutional review board 
of the Riga East University Hospital. 
Patient Selection. Forty-five patients (24 women 
and 21 men aged between 20 and 73 years, with 
an average age of 44 years) with a morphologically 
confirmed brain glioma underwent MR examina-
tion during the period between August 2009 and 
July 2011. All patients presented with a residual/
recurrent glioma after surgical resection and with 
or without following radiation and chemotherapy. 
Tumors were classified by using the World Health 
Organization (WHO) classification. The study in-
cluded 24 glioblastomas, 9 anaplastic astrocytomas, 
6 anaplastic oligoastrocytomas, 2 astrocytomas, 1 
oligoastrocytoma, 1 anaplastic oligodendroglioma, 
1 oligodendroglioma, and 1 anaplastic pleomorphic 
xanthoastrocytoma. The patients without a mor-
phologically confirmed brain glioma were excluded 
from this trial. 
MR Protocol. The patients were examined using 
a 1.5-Tesla MR system (GE Signa EXCITE MR) 
equipped with an 8-channel head coil. The MR 
protocol included the standard structural sequences 
T2-weighted, FLAIR, diffusion-weighted, and T1-
weighted imaging before and after the intravenous 
administration of gadolinium-based contrast medi-
um; DTI (TENSOR 25 directions 1000b) and MRS 
(8 ch) PROBE-2DSI PRESS 144TE. The imag-
ing parameters for DTI were as follows: scan tim-
ing: number of shots, 1; echo time (TE), minimum 
97.6; repetition time (TR), 8500 ms; acquisition 
timing: freq, 128; phase, 128; number of excitations 
(NEX), 1.00; phase field of view (FOV), 0.80; freq 
DIR, R/L; shim, auto; scanning range: field of view 
(FOV), 26.0; slice thickness, 5.0; spacing, 0.0; and 
number of slices, 27. The time required to acquire 
the DTI set was 3 minutes and 50 seconds. MRS 
was performed with 2D multivoxel chemical shift 
imaging using the following parameters: echo time, 
144 ms; repetition time, 1000 ms; NEX, 1; and ac-
quisition time, 4 minutes 20 seconds. The volume 
of interest of MRS was placed on axial T2-weight-
ed or FLAIR images including as much as possi-
ble of the lesion, the distant and the contralateral 
normal-appearing brain parenchyma, avoiding sub-
cutaneous fat and sinuses according to the previous 
recommended guidelines (20) as shown in Fig. 1B. 
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Fig. 1. MR images of a 48-year-old male with a recurrent anaplastic oligodendroglioma in the left frontal lobe
A, axial T1 image after contrast administration demonstrates a well-defined solid tumor portion with inhomogeneous contrast en-
hancement and perifocal edema; B, the location of the MRS volume of interest in the brain is outlined by a white square. ROIs were 
placed in the tumor center [1], perifocal edema [2], distant normal-appearing white matter [3], and contralateral normal-appearing 
white matter [4] for the calculation of the metabolite ratios; C, identical 4 ROIs placements are shown on the diffusion tensor map 
for the determination of the FA values; and D, the color-coded FA map on which the regions of high anisotropy are shown in red 
and the regions of low anisotropy are shown in blue.
A B
C D
MRS was acquired before the administration of the 
contrast agent.
Image Analysis. MR data processing was per-
formed on a MR Gels workstation (General Elec-
tric) by using Functool, a program for the visualiza-
tion and processing of DTI and MRS data.
To assess FA and metabolite changes in the dif-
ferent brain zones, 4 regions of interest (ROIs) were 
defined: the central part of the tumor, zone of peri-
focal edema, distant normal-appearing white mat-
ter, and contralateral normal-appearing white mat-
ter as illustrated in Fig. 1B–D. This selection was 
based on the previous recommendations (4, 21, 22). 
The region of tumor center was determined by us-
ing the structural MR scans – a region containing 
a well-defined solid portion, with or without con-
trast enhancement, and pathological signal intensity 
on T2-weighted and FLAIR images. The perifocal 
edema was delineated as a region with higher signal 
intensity on T2-weighted and FLAIR images, con-
taining no enhancement (Fig. 1A). The region of 
distant normal-appearing white matter was select-
ed in the distance of 5–10 mm from the visualized 
zone of perifocal edema. The region of contralateral 
normal-appearing white matter was selected in the 
symmetrical white matter zone of the opposite cere-
bral hemisphere. Both the distant and the contralat-
eral normal-appearing white matter contained nor-
mal signal intensity on all structural MR sequences.
DTI measure (FA) was calculated from diffusion 
tensor maps in each ROIs of similar size (30 pixels). 
Identical 4 mean metabolites ratios (NAA/Cr, Cho/
Cr, MI/Cr, and LL/Cr) were estimated using MRS 
maps.
To perform the repeatability analysis of DTI and 
MRS quantitative measurements, 20 patients with 
MR Study on Peritumoral Area of Cerebral Gliomas
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glial tumors were selected. The metabolite ratios 
and FA measurements were repeatedly measured 
using the identical methodology – ROIs were placed 
on the central part of the tumor, zone of perifocal 
edema, the distant and the contralateral normal-ap-
pearing white matter. Repeated measurements were 
done  at approximately 6-month intervals. Overall, 
398 repeated measurements were made. In order 
to create objective data, measurements were made 
blind regarding to previously chosen ROI localiza-
tions in the image slice and the voxel.
Statistical Analysis. Statistical analysis was per-
formed by using the Excel 2003 (Microsoft) and the 
Statistical Package for the Social Sciences (SPSS, 
version 20). Descriptive statistics were used for 
calculating the mean and standard deviations of 
the samples and the measures. The Kolmogorov-
Smirnov test was used to determine if the data were 
normally distributed. If the data were normally dis-
tributed (P>0.05), the paired sample t test was used 
to compare the values of means for 2 related sam-
ples. If the variables in paired samples did not meet 
the normal distribution (P<0.05), the nonparamet-
ric related samples Wilcoxon signed rank test was 
used to compare the pairs. 
The repeatability of measurements was tested 
with a single factor analysis of variance. The meas-
ure of repeatability (r) ranged from 0 to 1. The fol-
lowing terminology was used to describe various 
degrees of repeatability as recommended Martin 
and Bateson (1986): slight repeatability (r<0.2), low 
repeatability (r=0.2–0.4), moderate repeatability 
(r=0.4–0.7), high repeatability (r=0.7–0.9), and 
very high repeatability (r>0.9). This repeatability 
index was used only in cases when the data were 
statistically significant (23). 
A P value of less than 0.05 was considered to 
indicate a significant difference. 
Results
The data of DTI measurements (FA) and MRS 
parameters (NAA/Cr, Cho/Cr, MI/Cr, and LL/Cr 
ratios) are displayed in Table 1.
A gradual increase in the FA values and NAA/
Cr ratios and a gradual decrease in the Cho/Cr and 
LL/Cr ratios in the direction from the tumor cent-
er to the peritumoral zone were observed (Fig. 2). 
Region of Interest FA Cho/Cr NAA/Cr MI/Cr LL/Cr
Tumor center
Perifocal edema
Distant normal-appearing white matter





















Values are mean (standard deviation).
Cho, choline; Cr, creatine; NAA, N-acetylaspartate; LL, lactate/lipids; MI, myo-inositol.
Table 1. Fractional Anisotropy and Metabolite Ratios of 4 Selected Brain Regions Among Patients With Brain Glioma
Fig. 2. MRS images of the same case as in Fig. 1
A, typical MR spectrum of the tumor center from the ROIs 
[1] with an elevated LL peak and a reduced NAA peak; 
B, MR spectrum in the perifocal edema displays a reduced 
NAA peak and a gradually reduced LL peak in comparison 
with the tumor center; and C, MR spectrum in the contralat-
eral normal-appearing white matter shows a high NAA peak. 
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There were the significant differences (P<0.001) 
in the mean FA values comparing all regions stud-
ied, i.e., the tumor center, perifocal edema, distant 
normal-appearing white matter, and contralateral 
normal-appearing white matter. Similarly, the sig-
nificant differences in the mean LL/Cr ratio in all 
investigated regions were observed; the levels of 
significance between the tumor center and distant 
normal-appearing white matter; between the tumor 
center and contralateral normal-appearing white 
matter; between the perifocal edema and contralat-
eral normal-appearing white matter; between the 
perifocal edema and distant normal-appearing white 
matter, as well as between distant and contralateral 
normal-appearing white matter were P<0.001. The 
level of significance between the tumor center and 
the perifocal edema was P=0.04. 
Analyzing the Cho/Cr ratio, the significant dif-
ferences between the tumor center and the perifo-
cal edema (P=0.029), the tumor center and both 
the distant and the contralateral normal-appearing 
white matter (P<0.001), the perifocal edema and the 
distant normal-appearing white matter (P=0.013), 
and the perifocal edema and the contralateral nor-
mal-appearing white matter (P=0.011) were found. 
The difference in the mean Cho/Cr ratio between 
the distant and the contralateral normal-appearing 
white matter (P=0.973) was not significant.
The significant differences between the tumor 
center and the contralateral normal-appearing 
white matter (P=0.002), the perifocal edema and 
the contralateral normal-appearing white matter 
(P=0.002), and the distant and the contralateral 
normal-appearing white matter (P=0.003) were re-
corded. The difference in the mean NAA/Cr ratio 
between the tumor center and the perifocal edema, 
the tumor center and the distant normal-appearing 
white matter, the perifocal edema and the distant 
normal-appearing white matter was not significant 
(P values from 0.074 to 0.717).
The significant differences in the MI/Cr ratio 
were found only between the tumor center and the 
distant normal-appearing white matter (P=0.001) 
and the tumor center and the contralateral normal-
appearing white matter (P=0.019). The differences 
in the mean MI/Cr ratio were not significant be-
tween the other investigated regions (P values from 
0.077 to 0.843).
Analyzing the repeated measurements in 20 pa-
tients, the statistically significant differences were 
not observed in the tumor center between Cho/Cr 
measurements (P=0.180), NAA/Cr measurements 
(P=0.081), and MI/Cr measurements (P=0.789); 
in the perifocal edema, between Cho/Cr measure-
ments (P=0.273), MI/Cr measurements (P=0.285), 
LL/Cr measurements (P=0.347); in the distant 
normal-appearing white matter, between NAA/Cr 
measurements (P=0.500), MI/Cr measurements 
(P=0.686), LL/Cr measurements (P=0.528); in 
the contralateral normal-appearing white matter, 
between Cho/Cr measurements (P=0.577), LL/Cr 
measurements (P=0.093).
In 6 cases, the repeated measurements were sta-
tistically significantly different, so the repeatability 
index r was measured. Table 2 shows the summa-
ry of repeatability index analysis for the repeated 
measurements of MRS- and DTI-derived measures. 
Discussion
Understanding the invasion of brain glioma in 
the normal-appearing white matter still represents 
a challenge in neurooncological research. The fail-
ure of surgical resection in malignant gliomas is 
thought to be presumably caused by residual tumor 
cells located peripheral to the surgically removed 
part of the tumor, and also highly cellular tumor 
core (1, 24). We reviewed our MR imaging data on 
patients with histologically confirmed brain glioma. 
We combined FA and MRS measurements in order 
to determine whether they provide additional sta-
tistically feasible information on the possible glio-
mas cell infiltration in the peritumoral areas, which 
appear normal in the structural MR images. We 
found that in patients with glial brain tumors, the 
mean FA values increased significantly in the direc-
tion from the peritumoral zones toward the tumor 
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*F was calculated as the ratio of mean square between groups divided by mean square within groups.
Cho, choline; Cr, creatine; NAA, N-acetylaspartate; LL, lactate/lipids; MI, myo-inositol.
Table 2. Results of Repeatability in MRS- and DTI-Derived Measures on 20 Patients 
With Glial Brain Tumors Using Single Factor Analysis of Variance
MR Study on Peritumoral Area of Cerebral Gliomas
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center. Theoretically, this finding was expected be-
cause FA alterations are associated with the integrity 
of neurons (6), which decreases closer to the tumor 
center. Previous studies have shown that the perifo-
cal edema zone of glial brain tumors contains not 
only pure water, but also invasive tumor cells (4), 
microglial cells, and reactively altered astrocytes (5).
The nonsignificant differences in the mean 
NAA/Cr ratio between the tumor center and the 
perifocal edema, the tumor center and distant nor-
mal-appearing white matter, and the perifocal ede-
ma and the distant normal-appearing white matter 
indicate a particularly preserved presence of neu-
rons in tumor and peritumoral zones. That suggests 
the neuroscientific opinion that infiltrated brain 
tumor zones are still functioning brain tissues. Al-
though Cr is considered a stable metabolite, some 
authors have reported that its concentration may 
vary – Cr level is reduced in tumors, particularly 
high-grade gliomas (10). Our findings are contrary 
to those reported by Goebell et al. in their study (6). 
They found a significantly continuous reduction in 
the NAA/Cr values from the adjacent white mat-
ter to the tumor center. It could be explained by a 
difference between the present study and that one. 
Goebell et al. included only WHO grade II and grade 
III gliomas. The majority of our studied patients had 
WHO grade IV glioblastomas, which can lead to the 
decreased Cr concentration. Our study shows that the 
NAA/Cr ratio in the peritumoral regions provides a 
low diagnostic significance, because these measure-
ments in the tumor center, perifocal edema, and dis-
tant normal-appearing white matter are not different. 
The NAA/Cr ratio can be used to assess the changes 
in the distant and contralateral normal-appearing 
white matter, which appears to be identical in the 
structural MR images. In the distant normal-appear-
ing white matter around the perifocal edema, the val-
ues of NAA/Cr  ratio were lower that may indicate the 
replacement of normal neurons by tumor cells.
Analyzing the mean LL/Cr ratios, a significant 
gradual decrease in this ratio from the central to the 
peripheral area was found. This indicates the great-
er necrotic changes closer to the tumor center. As 
shown in the previous studies (8, 14), the levels of 
lipids detected on MRS correlated well with the his-
tological degree of necrosis. Our first finding sug-
gests that the LL/Cr ratio may be even sensitive in 
the early detection of peritumoral infiltration with 
a few malignant cells. However, it must be taken 
in into account that we investigated patients previ-
ously treated with radiotherapy and chemotherapy, 
so the changes in the LL/Cr ratio could also be ex-
plained by posttreatment effects. Some authors have 
reported an increased lipid peak after radiotherapy 
(14). We detected a statistically significant differ-
ence in the LL/Cr ratio between the distant and the 
contralateral normal-appearing white matter. Our 
findings are consistent with the previous observa-
tions that no abnormal lipid peak is detected in the 
healthy brain (8). Our results on a gradual reduction 
in the LL/Cr ratio in the direction from the tumor 
center to the periphery match with the previous 
published morphological observations that the ma-
jority of gliomas recur within 2.5cm of the resection 
margin (3), where histologically some invasive cells 
are identified (6).
We suggest that LL/Cr ratios and FA values may 
have the superior implications in the detecting of 
glial tumors extent. In our study, the significant dif-
ferences in the mean LL/Cr ratio and the mean FA 
value between tumor and peritumoral regions (peri-
focal edema and distant normal-appearing white 
matter) were found. 
Similarly, our study showed a gradual decrease 
in the Cho/Cr ratio in the direction from the tumor 
center toward the perifocal edema and the distant 
normal-appearing white matter zone. Whereas there 
is an increased Cho level in areas with an elevated 
cell membrane turnover, such as in growing tumors 
(8), this could indicate a gradual decrease in the 
concentration of tumor cells in these zones. We sug-
gest that the Cho/Cr ratio is a less sensitive and spe-
cific indicator of the distal zone of glial tumor where 
tumor cells are presented in low concentrations as 
there was no statistically significant difference in the 
Cho/Cr ratio between the distant and the contralat-
eral normal-appearing white matter. We suggest that 
the Cho/Cr ratio could provide additional informa-
tion about the zone of perifocal edema where the 
concentration of tumor cells is higher.
In our study, the MI/Cr ratio showed the most 
inferior diagnostic performance for the evaluation of 
peritumoral area. Similarly Chernov et al. also did 
not find a statistically significant difference in the 
MI/Cr ratio between tumor and perilesional brain 
tissue (25). Some studies suggested that MI levels 
might have a role in the grading of cerebral gliomas. 
Castillo et al. found an elevated level of MI in low 
grade astrocytomas (26). We found a significant dif-
ference in the MI/Cr ratio only between the tumor 
center and the normal-appearing white matter. The 
present study indicates that the MI/Cr ratio of the 
peritumoral area will not improve the accuracy of 
diagnosis.
Wright et al. developed a novel color mapping 
technique for the visualization of tumor infiltration 
zone based on DTI and MRS measurements. The 
MRS and DTI measurements were investigated in 
3 brain areas to determine tumor infiltration. They 
divided the normal brain zone, but did not specify 
whether it is localized around the perifocal edema 
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or in the contralateral cerebral hemisphere (1). We 
separately investigated distal and contralateral nor-
mal signal intensity areas and found differences in 
the LL/Cr and NAA/Cr ratios and FA measure-
ments. It is consistent with the previous statements 
that the brain areas of normal signal intensity may 
have a different degree of tumor cell infiltration, 
with a gradual decrease in the direction from the 
tumor core toward the contralateral normal brain. 
These results indicate that functional MR gives ad-
ditional information not only on the tumor core and 
the perifocal edema, but also on functional changes 
in the brain areas of normal signal intensity. DTI and 
MRS add a relevant diagnostic value that far exceeds 
the information of structural MR imaging alone. 
Many researchers have studied the role of MRS 
and DTI quantitative measurements in the diagnosis 
and monitoring of glial tumors, but only few au-
thors have tested whether these measurements are 
repeatable. To our knowledge, this is the first study 
that evaluated the repeatability index of MRS and 
DTI measures in the peritumoral areas of glial brain 
tumors. We tested the repeatability of metabolite 
ratios and FA values in 20 different measurements 
groups (Cho/Cr, MI/Cr, LL/Cr, NAA/Cr, and FA 
in 4 different areas). Our study demonstrated the 
high levels of repeatability in 14 MRS and DTI 
measures. In 6 cases, the repeated measurements 
were statistically significantly different, so the re-
peatability index r was calculated. In 4 cases (LL/
Cr ratio in the tumor center, NAA/Cr ratio in the 
perifocal edema, Cho/Cr ratio in the distant nor-
mal-appearing white matter, and MI/Cr ratio in 
the contralateral normal-appearing white matter), 
high reproducibility was obtained. Only NAA/Cr 
and FA measurements in the contralateral area of 
normal signal intensity showed a moderate repeat-
ability. This could be due to the subjective selection 
of ROIs, as well as the fact that these measurements 
depend on various neural densities in the differ-
ent zones. ROI tracking choices in the contralateral 
normal-appearing white matter are subjective. Al-
though it is determined according to the area of the 
opposite hemisphere lesion, there might be varia-
tions between adjacent voxels. Both NAA and FA 
indicate the presence of neurons; however, our data 
suggest that FA repeatability is lower than that of 
NAA/Cr ratio. These differences could be explained 
by differences in MRS and DTI test methodology. 
MRS is scanned in the one selected image plane, in 
which the following measurements are also carried 
out. DTI examination includes all areas of the brain, 
resulting in approximately 27 axial slices. When 
the measurements of FA were repeated, the ROIs 
were selected  blindly to the previous localizations 
of ROIs; therefore, the deviation in ROI selection 
could have been also between adjacent planes, not 
only between adjacent voxels, as it is in the MRS 
measurements. In addition, the course of white 
matter fibers may vary between adjacent voxels – 
in the zones where fibers run parallel or neurons 
have a more dense arrangement, the values of FA 
and NAA  will be higher. Therefore, the differences 
between adjacent voxels could also be explained by 
anatomical features, not only by the disease pro-
gression or treatment effects. The visual overview 
of neuron integrity can be obtained by using the 
color-coded DTI FA maps. The red color visualizes 
the areas with the largest anisotropy, where most of 
the fibers run to the same direction, but the blue 
color shows the areas with the lowest anisotropy. 
However, in these maps, it is difficult to distinguish 
the tumor area with an extremely reduced number 
of neurons from the postoperative cavity – these 
areas in FA color maps may look identical to the 
isotropic diffusion (blue). Therefore, ROIs for the 
FA measurement are easier to draw on the primary 
gray-scale DTI images, in which the visible tumor 
mass can be clearly distinguished from the perifocal 
edema as well as the easily visualized postoperative 
cavity edge. To improve the measurement accuracy 
of FA, the ROIs could be draw on the primary DTI 
images, but at the same time taking into account 
the color-coded FA map, where defined ROIs ap-
pear automatically. Also, NAA/Cr measurements 
in contralateral cerebral showed a moderate repeat-
ability. Perhaps it could also occur due to different 
measurement site selection between adjacent vox-
els. This discrepancy could be reduced if ROIs are 
chosen in accordance with the DTI color-coded FA 
maps, which show the areas with different neuronal 
density. MRS measurements are made either on the 
axial T2 or FLAIR images of the brain, where white 
matter produces a homogeneous signal regardless 
of neuron density. These conventional MR imag-
es do not provide information about the amount 
of neurons in the different areas of white matter. 
Some authors reported a very high repeatability of 
FA measurements in the central part of the tumor 
(r=0.947) (19). In our study, FA from the tumor 
center did not show a statistically significant dif-
ference, indicating the high level of repeatability. 
However, that study used a slightly different meth-
odology, since the repeated measurements were 
performed approximately 48 hours apart (19). In 
our study, the interval was much longer, i.e., about 
6 months, which may affect the repeated measure-
ments in terms of when the measurements were not 
read out in identical measurement areas.
Our study has some limitations. First, we admit 
that radiation therapy and chemotherapy applied to 
the patients may have an influence on the FA val-
MR Study on Peritumoral Area of Cerebral Gliomas
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ues and metabolite ratios that were measured in the 
tumor and peritumoral areas (6, 27). Recent publi-
cations have shown that radiation therapy can alter 
Cho, Cr, NAA, and LL (28) levels and FA values 
(29). We assume that further studies involving a pa-
tients’ cohort with a primary diagnosed glioma be-
fore the treatment might expand our results. The 
second limitation is the lack of separate histological 
evaluation of the perifocal edema in all cases and in 
the distant normal-appearing white matter. A previ-
ously reported postmortem neuropathological study 
reported that invasive tumor cells were detected sev-
eral centimeters beyond the malignant glioma bed 
and consisted of small anaplastic cells and small fi-
brillated cells (30). 
Considering the additional sequences in the 
standard examinations, we analyzed a number of 
advantages and drawbacks of the techniques used 
(DTI or MRS alone versus DTI plus MRS):
• Additional MR sequences markedly increase the 
examination expenses. When functional MR series 
are included in the standard MR protocol, the cost 
increases by about 44.65%. These expenses do not 
change regardless of 1 or 2 additional functional 
MR sequences are used.
• Additional MR sequences prolong examination 
time. The duration of conventional MR scan in pa-
tients with glial brain tumor is approximately 12 min-
utes 47 seconds. With both DTI and MRS, the ex-
amination duration increases by 7 minutes 7 seconds. 
Accordingly, if we use only one of these sequences, 
examination extends by 3 minutes 50 seconds (DTI) 
or 4 minutes 20 seconds (MRS case). In general, pa-
tients tolerated the examination well; we did not in-
terrupt examination before the end of the scan.
• DTI or MRS sequences require no additional 
contrast injection or other invasive manipulation, 
these examinations are painless. Main unpleasant 
factors that affect patient comfort are the same as in 
conventional MR examination sequences – a person 
must lie motionless in an enclosed tube; MR scan-
ners are usually very noisy.
• MRS and DTI image postprocessing is time-con-
suming. Using one or more additional sequences 
the image reconstruction and interpretation time is 
extending before a radiologist gives the answer. The 
total scan time and image postprocessing includ-
ing DTI and MRS analysis take about 1 hour. In 
comparison, conventional MR scanning and image 
analysis requires about 30 minutes.
• The combination of MRS and DTI sequences 
gives more valuable information than only one of 
the abovementioned MR methods. DTI provides a 
quantitative parameter, FA, which implies the in-
tegrity of white matter fibers, while MRS provides 
information about brain metabolism and metabolic 
changes in pathological processes. The combination 
of both methods increases the accuracy of measure-
ments – DTI color-coded FA images can be used for 
ROI selection of both FA and MRS measurements. 
These FA maps visualize the areas of white matter 
with different fiber connectivity. Measurements of 
FA and NAA/Cr may vary within the areas of dif-
ferent neuronal density. Therefore, to get the correct 
results, comparative measurements must be done in 
normal white matter areas with similar FA values.
The measurement results must be accurate, re-
peatable, so they can be used for follow-up in deter-
mining the distribution of glial tumors and evaluat-
ing the results of treatment and disease progression. 
We consider 6 conditions relevant when perform-
ing MRS and DTI measurements from the different 
zones of pathological and normal brain tissues in 
clinical practice. First, select the appropriate slice 
for MRS examination; it must include a tumor, a 
perifocal edema area, as well as the distal and the 
contralateral normal white matter. Second, the 
MRS plane must be consistent with the DTI select-
ed image slice for FA measurements. Third, choose 
the same plane in repeated MR scans for follow-up 
dynamics after the treatment. Fourth, the selected 
ROIs for both MRS and DTI measurements must 
be localized in the identical areas. Fifth, one must 
be very accurate when conducting measurements 
in the normal contralateral cerebral hemisphere – it 
is recommended to use DTI color-coded FA maps 
for ROI selection, which visualize the areas of white 
matter with different fiber connectivity. Compara-
tive measurements must be done in the areas of 
normal white matter with similar FA values. Sixth, 
the repeated measurements should be performed by 
one experienced neuroradiologist to avoid errors 
due to the subjective interpretation. 
Due to the limitations of DTI and MRS tech-
niques (expensive, time-consuming), it is necessary 
to clarify the indications for this additional function-
al imaging. We believe that the main indications are 
patients with newly diagnosed glial tumors before 
the planned surgical treatment, as well as previously 
treated patients with new structural changes around 
the surgical cavity on conventional MR imaging. 
In cases when the data of conventional MR exami-
nation during follow-up are unchanged compared 
with the previous data, and the clinical condition is 
stable, additional functional MR examinations may 
be omitted. When additional functional sequences 
are used, we recommend combining both DTI and 
MRS examinations.
Our data confirmed that an elevation in the 
Cho/Cr and LL/Cr ratios with the reduction of FA 
is a reliable indicator of the infiltration of brain gli-
oma cells outside the visible tumor border. These 
Anvita Bieza, Gaida Krumina
505
Medicina (Kaunas) 2012;48(10)
pathophysiological changes in the peritumoral area 
demonstrated by MRS and DTI can assist in choos-
ing a biopsy target for brain gliomas, planning the 
surgical removal or fields and limited target zones 
of radiation therapy. Our findings have important 
implications for the use of DTI and MRS sequences 
in clinical practice. Our study shows that the MRS 
and DTI measurements are reproducible. The MRS 
and DTI measurements of cerebral gliomas and 
peritumoral area have a high degree of repeatability. 
In order to assess the changes in white matter after 
received therapy and to compare with the previous 
MR examinations, it is necessary to follow the ac-
curate methodology. A greater accuracy of measure-
ment is required for comparison with the contralat-
eral normal-appearing white matter. 
Conclusions
Our study shows that the MRS and DTI meas-
urements are reproducible. Estimated DTI and 
MRS data in the peritumoral zone of gliomas de-
tected abnormalities despite the normal-appearing 
white matter on structural MR images. We conclude 
that the combined use of Cho/Cr and LL/Cr ratios 
and FA measurements is a promising MR technique 
that provides valuable additional information on the 
extent of real tumor spread along the white matter 
tracts and location of its potential border.  
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